Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among…

@inform_ts これのことね。 そういうの提示するなら、記事ではなくCDCから持ってきた方がいいよ。 一応確認したが、このデータ、接種から2週間未満の人を未接種扱いにしてるね。要は、統計詐欺してる。 しかも、比較対象が以前コロナワクチンを接種した人で、非接種者との比較でもない。 https://t.co/Tc2JC5V4tR

RT @deonandan: The bivalent booster came out in Sep/2022. It was able to prevent actual infection by ~54%, which means it was also signific…

RT @deonandan: The bivalent booster came out in Sep/2022. It was able to prevent actual infection by ~54%, which means it was also signific…

RT @deonandan: The bivalent booster came out in Sep/2022. It was able to prevent actual infection by ~54%, which means it was also signific…